In conclusion, CSS may regulate the activity of immune‐related factors in the tumour microenvironment, reverse immune escape, enhance immune responses through AKT1, MAPK3, and CASP3, and synergistically alleviate HCC. Here, AKT1 is linked to hepatocellular carcinoma.